Home > Insider Trading > Filing (0001209191-12-027992)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337801	W Randal Scott	301 Penobscot Drive Redwood City CA 94403	Ceo, Invitae Corporation*	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-05-10	14,600	$29.92	1,260,517	No	4	S	Direct
Common Stock	Disposition	2012-05-10	400	$30.29	1,260,117	No	4	S	Direct
Common Stock	Disposition	2012-05-11	7,200	$30.00	1,252,917	No	4	S	Direct
Common Stock	Disposition	2012-05-11	5,620	$30.85	1,247,297	No	4	S	Direct
Common Stock	Disposition	2012-05-11	2,180	$31.39	1,245,117	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,298	Indirect	By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA
Common Stock	3,466	Indirect	Held in trust for the benefit of Dr.Scott's children, of which Dr. Scott's sister is trustee.

Footnotes

These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 11, 2011.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $29.21 to $30.15.
Includes 4,600 restricted stock units awarded February 5, 2012 which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014 and 1/3 of the shares on February 15, 2015.
Includes 4,500 restricted stock units awarded January 27, 2011, of which 1/3 of the shares vest on each of February 15, 2013 and 2014, and the 1/3 of the shares that vested on February 15, 2012, net of withholding.
Represents weighted average sale price. Actual sale prices ranged from $30.24 to $30.30.
Represents weighted average sale price. Actual sale prices ranged from $29.24 to $30.20.
Represents weighted average sale price. Actual sale prices ranged from $30.25 to $31.24.
Represents weighted average sale price. Actual sale prices ranged from $31.28 to $31.60.